Skip to content

Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens

Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05765227
Enrollment
18
Registered
2023-03-13
Start date
2023-03-08
Completion date
2023-03-30
Last updated
2024-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Ametropia

Keywords

Presbyopia

Brief summary

The purpose of this clinical trial was to evaluate the clinical performance of a manufacturing process on a frequent replacement multifocal contact lens.

Detailed description

Subjects will be expected to attend 3 scheduled visits. Eligible subjects will wear each study lens type in a cross-over fashion for approximately 2 days.

Interventions

Investigational silicone hydrogel multifocal contact lenses

Commercially available silicone hydrogel multifocal contact lenses

Commercially available cleaning and disinfection system for silicone hydrogel contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Able to understand and sign an consent form (ICF) that has been approved by an Institutional Review Board (IRB); * Willing to stop wearing habitual contact lenses for the duration of study participation; * Currently wearing multifocal soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months; * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Any eye infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator; * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator; * History of refractive surgery, or plan to have refractive surgery during the study; * Current or history of dry eye in either eye that would preclude contact lens wear, in the opinion of the investigator; * Monovision contact lens wear; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)Day 2, each study lens type worn during the corresponding crossover periodVA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 1 investigative site located in 1 country (US).

Pre-assignment details

Of the 18 enrolled, 1 participant was exited prior to study start as a screen failure. This reporting group includes all participants exposed to any study lenses evaluated in this study (17).

Participants by arm

ArmCount
LID#224381, Then AOHG MF
Lehfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
8
AOHG MF, Then LID#224381
Lotrafilcon B multifocal contact lenses worn first, with lehfilcon A multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
9
Total17

Baseline characteristics

CharacteristicAOHG MF, Then LID#224381TotalLID#224381, Then AOHG MF
Age, Continuous62.4 years
STANDARD_DEVIATION 5.2
63.2 years
STANDARD_DEVIATION 4.7
64.1 years
STANDARD_DEVIATION 4.3
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants17 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants3 Participants1 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
White
7 Participants14 Participants7 Participants
Sex: Female, Male
Female
1 Participants4 Participants3 Participants
Sex: Female, Male
Male
8 Participants13 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 340 / 170 / 340 / 17
other
Total, other adverse events
0 / 170 / 340 / 170 / 340 / 17
serious
Total, serious adverse events
0 / 170 / 340 / 170 / 340 / 17

Outcome results

Primary

Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)

VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.

Time frame: Day 2, each study lens type worn during the corresponding crossover period

Population: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.

ArmMeasureValue (MEAN)Dispersion
LID#224381Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)-0.08 logMARStandard Deviation 0.06
AOHG MFBinocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)-0.06 logMARStandard Deviation 0.06

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026